TITLE
Masitinib-gemcitabin effect on gemcitabine-refractory Mia Paca-2 pancreatic tumor cell line

SUMMARY
Analysis of Mia Paca2 cells after treatment with masitinib combined with standard gemcitabine chemotherapy. Masitinib is a tyrosine kinase inhibitor of c-Kit, PDGFRα and β. Results provide insight into the therapeutic potential of masitinib in vitro on human pancreatic tumor cell lines.

ORGANISM
Homo sapiens

PLATFORM
GPL570 : [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array

CITATIONS
Humbert M, Castéran N, Letard S, Hanssens K et al. Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model. PLoS One 2010 Mar 4;5(3):e9430. PMID:  20209107 Sabatier R, Finetti P, Adelaide J, Guille A et al. Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer. PLoS One 2011;6(11):e27656. PMID:  22110708

